Search Results - "Urinary Bladder radiation effects"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2
  3. 3

    Source: Strahlenther Onkol

    Subject Terms: Male, Organs at Risk, Gastrointestinal Diseases, Aged, 80 and over [MeSH], Localized prostate cancer, Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], Seminal Vesicles/radiation effects [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Seminal Vesicles/pathology [MeSH], Prostatic Neoplasms/radiotherapy [MeSH], Organ Sparing Treatments/methods [MeSH], Original Article, Rectum/radiation effects [MeSH], Gastrointestinal Diseases/prevention, Male [MeSH], Adenocarcinoma/pathology [MeSH], Gastrointestinal toxicity, Radiation Dose Hypofractionation [MeSH], Adenocarcinoma/radiotherapy [MeSH], Simultan integrierter Boost, Propensity Score [MeSH], Radiation Injuries/etiology [MeSH], Tumor Burden [MeSH], Adenocarcinoma/blood [MeSH], Radiotherapy, Intensity-Modulated/methods [MeSH], Genitourinary toxicity, Follow-Up Studies [MeSH], Urogenitale Toxizität, Cystitis/etiology [MeSH], Humans [MeSH], Moderat hypofraktionierte Strahlentherapie, Moderately hypofractionated radiotherapy, Retrospective Studies [MeSH], Lokal begrenztes Prostatakarzinom, Middle Aged [MeSH], Radiotherapy, Intensity-Modulated/adverse effects [MeSH], Gastrointestinal Diseases/etiology [MeSH], Organs at Risk/radiation effects [MeSH], Time Factors [MeSH], Proctitis/etiology [MeSH], Urination Disorders/etiology [MeSH], Urinary Bladder/radiation effects [MeSH], Gastrointestinale Toxizität, Cystitis/pathology [MeSH], Radiation Injuries/prevention, Simultaneous integrated boost, Proctitis/prevention, Urination Disorders/pathology [MeSH], Adenocarcinoma, 03 medical and health sciences, 0302 clinical medicine, Cystitis, Humans, Proctitis, Propensity Score, Radiation Injuries, Aged, Retrospective Studies, Aged, 80 and over, 2. Zero hunger, Rectum, Prostatic Neoplasms, Middle Aged, Prostate-Specific Antigen, 3. Good health, Radiation Dose Hypofractionation, Radiotherapy, Intensity-Modulated, Organ Sparing Treatments, Follow-Up Studies

  4. 4

    Source: Hysing, L B, Ekanger, C, Zolnay, Á, Helle, S I, Rasi, M, Heijmen, B J M, Sikora, M, Söhn, M, Muren, L P & Thörnqvist, S 2018, 'Statistical motion modelling for robust evaluation of clinically delivered accumulated dose distributions after curative radiotherapy of locally advanced prostate cancer', Radiotherapy & Oncology, vol. 128, no. 2, pp. 327-335. https://doi.org/10.1016/j.radonc.2018.06.004

  5. 5

    Source: UroGEC/BRAPHYQS group of the GEC ESTRO 2016, 'Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer', Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, vol. 120, no. 2, pp. 293-9. https://doi.org/10.1016/j.radonc.2016.05.026

    File Description: application/pdf

  6. 6

    Contributors: Eun Ji Nam Gwi Eon Kim Woong Sub Koom et al.

    Source: Gynecologic Oncology. 139:439-446

  7. 7
  8. 8

    Authors: Fonteyne V Soete G Arcangeli S et al.

    Contributors: Fonteyne V Soete G Arcangeli S et al.

    Source: International Journal of Radiation Oncology*Biology*Physics. 84:e483-e490

    File Description: application/pdf

  9. 9

    Source: International Journal of Radiation Oncology, Biology, Physics, Vol. 84, No 3 (2012) pp. e311-8

    File Description: application/pdf

  10. 10

    Source: International Journal of Radiation Oncology, Biology, Physics, Vol. 78, No 1 (2010) pp. 50-57

    File Description: application/pdf

  11. 11
  12. 12

    Source: Mens, J W, Slotman, B J, Meijer, O W & Langendijk, H A 2000, 'Effect of CT-based treatment planning on portal field size and outcome in radiation treatment of localized prostate cancer', Radiotherapy and Oncology, vol. 55, no. 1, pp. 27-30.

  13. 13
  14. 14
  15. 15